TCR Engineered T Cell Therapy has shown promise in treating a variety of cancers, including but not limited to, melanoma, sarcomas, and certain types of leukemia. The effectiveness of this therapy largely depends on the identification of specific cancer antigens that can be targeted by the engineered TCRs.
